IL-6: a cytokine at the crossroads of autoimmunity
- 1 December 2018
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 55, 9-14
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1 DP3 DK104466, 5 R01 AI132774)
This publication has 61 references indexed in Scilit:
- Functional IL6R 358Ala Allele Impairs Classical IL-6 Receptor Signaling and Influences Risk of Diverse Inflammatory DiseasesPLOS Genetics, 2013
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cellsJournal of Experimental Medicine, 2012
- Increased Frequency of Circulating Follicular Helper T Cells in Patients with Rheumatoid ArthritisJournal of Immunology Research, 2012
- IL-6 Signaling in Psoriasis Prevents Immune Suppression by Regulatory T CellsThe Journal of Immunology, 2009
- Reduced CD4+,CD25− T cell sensitivity to the suppressive function of CD4+,CD25high,CD127−/low regulatory T cells in patients with active systemic lupus erythematosusArthritis & Rheumatism, 2008
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T CellsImmunity, 2006
- Treatment of rheumatoid arthritis with humanized anti–interleukin‐6 receptor antibody: A multicenter, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2004
- Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic CellsScience, 2003
- Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritisEuropean Journal of Immunology, 1988